Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life
PHASE2CompletedINTERVENTIONAL
Enrollment
240
Participants
Timeline
Start Date
April 30, 2014
Primary Completion Date
September 30, 2014
Study Completion Date
March 31, 2015
Conditions
Polio
Interventions
BIOLOGICAL
b-OPV
BIOLOGICAL
m-OPV2
BIOLOGICAL
m-IPV HD
BIOLOGICAL
t-IPV
Trial Locations (1)
Unknown
Hospital del Niño, Panama City
All Listed Sponsors
collaborator
Bill and Melinda Gates Foundation
OTHER
lead
Vaxtrials S.A.
OTHER
NCT02111135 - Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life | Biotech Hunter | Biotech Hunter